Dr. Waxman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-525-9733Fax+1 617-264-6873
Summary
- Dr. Aaron Waxman is a pulmonologist in Boston, MA and is affiliated with multiple hospitals in the area, including Brigham and Women's Faulkner Hospital and Brigham and Women's Hospital. He received his medical degree from Yale University School of Medicine and has been in practice 25 years. He specializes in critical care medicine, and pulmonary vascular medicine and is experienced in right-sided heart failure, pulmonary hypertension, pulmonary embolism, congestive heart failure, and pulmonary vascular disease.
Education & Training
- Yale-New Haven Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1995 - 1998
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1994
- Yale-New Haven Medical CenterInternship, Internal Medicine, 1991 - 1992
- Yale School of MedicineClass of 1992
- Albany Medical CollegePh.D., Anatomy and Neuroscience, 1987
- George Washington UniversityB.S., Zoology, 1978
Certifications & Licensure
- MA State Medical License 1993 - 2026
- UT State Medical License 2009 - 2026
- FL State Medical License 2012 - 2021
- CT State Medical License 1994 - 2002
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Best Doctors in Boston Boston Magazine, 2007, 2016, 2018-2024
- Distinguished Clinician Brigham and Women's Hospital, 2022
- Excellence in Mentoring Award Harvard Medical School, 2014
- Join now to see all
Clinical Trials
- Protocolized Care for Early Septic Shock Start of enrollment: 2008 Mar 01
- Study of Cicletanine for Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2009 Jan 01
- A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension Start of enrollment: 2011 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 85 citationsNEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertensionAndriy O. Samokhin, Thomas E. Stephens, Bradley M. Wertheim, Rui-Sheng Wang, Sara O. Vargas
Science Translational Medicine. 2018-06-13 - 134 citationsNoninvasive Assessment of Murine Pulmonary Arterial Pressure Validation and Application to Models of Pulmonary HypertensionHelene Thibault, Baptiste Kurtz, Michael J. Raher, Rahamthulla S. Shaik, Aaron B. Waxman
Circulation. Cardiovascular Imaging. 2010-03-01 - 56 citationsSotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension.Marc Humbert, Vallerie McLaughlin, J Simon R Gibbs, Mardi Gomberg-Maitland, Marius M Hoeper
The European Respiratory Journal. 2023-01-01
Journal Articles
- Pulmonary vascular morphology as an imaging biomarker in chronic thromboembolic pulmonary hypertensionRahaghi, F.N., Ross, J.C., Agarwal, M., Gonzalez, G., Come, C.E., Diaz, A., Sanchez-Ferrero, G.V., Andetta, H., Jose Estapar, R.S., Waxman, A.B., Washko, G.R., Pulmonary Circulation, 1/1/2016
- Portopulmonary Hypertension, Challenges in Diagnosis and ManagementTroy P, Waxman AB, Therapeutic Advances in Gastroenterology, 1/1/2009
- Plasma Gelsolin is a Marker and Therapeutic Agent in Animal SepsisLee PS, Waxman AB, Cotich KL, Chung SW, Perrella MA, Stossel TP, Critical Care Medicine, 1/1/2007
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Exercise Intolerance in Preload Failure Treated with Pyridostigmine.M. Faria Urbina, R. Oliveira, A. Oaklander, A. B. Waxman, D. M. Systrom, American Thoracic Society, San Diego, CA, 1/1/2018
- Right Ventricular-Pulmonary Arterial Uncoupling During Exercise in Pulmonary Hypertension.I. Singh, F. N. Rahaghi, M. Faria Urbina, R. K. Oliveira, T. Bachman, A. B. Waxman, D. M. Systrom, American Thoracic Society, San Diego, CA, 1/1/2018
- Impaired Systemic Oxygen Extraction in Treated Exercise Pulmonary Hypertension: A New Engine in an Old Car?M. Faria Urbina, R. Oliveira, S. Segrera, L. Lawler, A. B. Waxman, D. M. Systrom, American Thoracic Society, San Diego, CA, 1/1/2018
- Join now to see all
Lectures
- Totally Implantable Subcutaneous Devices for Continuous Prostanoid Delivery.University of California, San Francisco, San Francisco, CA - 1/1/2018
- Explaining unexplained exertional dyspnea: Application of the full Fick Principle.Norwalk Hospital, Norwalk, CT - 1/1/2018
- Invasive cardiopulmonary exercise testing to predict outcomes in heart failure preserved ejection fraction.University of Utah School of Medicine, Salt Lake City, UT - 1/1/2018
- Join now to see all
Other
- Approach to the patient with Dyspnea.Badr Eslam, R., Waxman, A.B., Scientific American Medicine, Pulmonary Medicine, Decker
https://www.deckerip.com/decker/scientific-american-medicine/chapter/115/
1/8/2016 - Advanced Prostanoid Therapy in PAH: The Time to Be Proactive Is Now!Waxman, AB, Chakinala, MM, Frantz, RP
http://www.medscape.org/viewarticle/755179
1/22/2011 - Diagnosis to Treatment: Facing the Challenges of Pulmonary Arterial Hypertension.Waxman AB, Clinical Case Challenge
1/1/2010 - Join now to see all
Press Mentions
- Pulmonary Hypertension Year in Review: Inhaled Therapy, Improving Mortality Trends in USJanuary 18th, 2022
- Why Am I so Tired After Working Out? It Could Be ‘Exercise Intolerance.’October 22nd, 2021
- Time from PAH Diagnosis Impacts Prognosis, Response to SelexipagAugust 5th, 2021
- Join now to see all
Grant Support
- IL-6 Type Cytokine Protection From Hyperoxic Lung InjuryNational Heart, Lung, And Blood Institute2004–2007
- Interleukin 11 Protection Hyperoxia Induced Lung InjuryNational Heart, Lung, And Blood Institute2001–2002
- Interleukin 11 Protection Hyperoxia Induced Lung InjuryNational Heart, Lung, And Blood Institute1999–2001
- Interleukin 11 Protection Hyperoxia Induced Lung InjuryNational Heart, Lung, And Blood Institute1998–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: